EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.

Détails

ID Serval
serval:BIB_49267A15C118
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force.
Périodique
European Journal of Neurology
Auteur⸱e⸱s
Management of Amyotrophic Lateral Sclerosis: , Andersen P.M., Andersen P.M., Abrahams S., Borasio G.D., de Carvalho M., Chio A., Van Damme P., Hardiman O., Kollewe K., Morrison K.E., Petri S., Pradat P.F., Silani V., Tomik B., Wasner M., Weber M.
Collaborateur⸱rice⸱s
EFNS Task Force on Diagnosis
ISSN
1468-1331 (Electronic)
ISSN-L
1351-5101
Statut éditorial
Publié
Date de publication
2012
Volume
19
Numéro
3
Pages
360-375
Langue
anglais
Notes
Publication types: Journal Article ; Practice Guideline Publication Status: ppublish
Résumé
BACKGROUND: The evidence base for the diagnosis and management of amyotrophic lateral sclerosis (ALS) is weak.
OBJECTIVES: To provide evidence-based or expert recommendations for the diagnosis and management of ALS based on a literature search and the consensus of an expert panel.
METHODS: All available medical reference systems were searched, and original papers, meta-analyses, review papers, book chapters and guidelines recommendations were reviewed. The final literature search was performed in February 2011. Recommendations were reached by consensus.
RECOMMENDATIONS: Patients with symptoms suggestive of ALS should be assessed as soon as possible by an experienced neurologist. Early diagnosis should be pursued, and investigations, including neurophysiology, performed with a high priority. The patient should be informed of the diagnosis by a consultant with a good knowledge of the patient and the disease. Following diagnosis, the patient and relatives/carers should receive regular support from a multidisciplinary care team. Medication with riluzole should be initiated as early as possible. Control of symptoms such as sialorrhoea, thick mucus, emotional lability, cramps, spasticity and pain should be attempted. Percutaneous endoscopic gastrostomy feeding improves nutrition and quality of life, and gastrostomy tubes should be placed before respiratory insufficiency develops. Non-invasive positive-pressure ventilation also improves survival and quality of life. Maintaining the patient's ability to communicate is essential. During the entire course of the disease, every effort should be made to maintain patient autonomy. Advance directives for palliative end-of-life care should be discussed early with the patient and carers, respecting the patient's social and cultural background.
Mots-clé
Advisory Committees, Amyotrophic Lateral Sclerosis/diagnosis, Amyotrophic Lateral Sclerosis/therapy, Evidence-Based Medicine, Humans
Pubmed
Web of science
Open Access
Oui
Création de la notice
05/02/2013 16:00
Dernière modification de la notice
20/08/2019 14:56
Données d'usage